We used primary cultures of rat hepatocytes to evaluate the effects of glucocorticoids on insulin-responsive hepatic lipogenesis. The data indicate that hepatocytes incubated for 20 h with dexamethasone (0.1 M) alone are profoundly resistant to the ability of insulin to stimulate lipogenesis acutely. In contrast, primary cultures of hepatocytes incubated with dexamethasone plus insulin are hyper-responsive to the ability of insulin to stimulate lipogenesis chronically. This potentiation of insulin action by a glucocorticoid occurs at physiological concentrations of the two hormones. Exposure to dexamethasone plus insulin for more than 4h is required for the two hormones to enhance insulin action either by overcoming the insulin resistance induced by dexamethasone alone or by stimulating insulin action induced by insulin alone. Despite the marked potentiation of insulin action, hepatocytes exposed to dexamethasone plus insulin are less sensitive to insulin, as demonstrated by a shift to the right in the dose-response curve for insulin-stimulated lipogenesis. The resistance of hepatocytes to the acute effects of insulin after exposure to dexamethasone alone and the potentiation of insulin action and decreased sensitivity to insulin after exposure to insulin plus dexamethasone are all mediated by post-insulin-binding events. These studies demonstrate potentiation of insulin action in the liver by physiological concentrations of glucocorticoids and may have physiological significance for the regulation of normal hepatic lipogenesis, for the hyperlipidaemia observed with the pharmacological use of glucocorticoids, and for disease states in man associated with hyperinsulinaemia and hypercortisolism.
We used primary cultures of rat hepatocytes to evaluate the effects of glucocorticoids on insulin-responsive hepatic lipogenesis. The data indicate that hepatocytes incubated for 20 h with dexamethasone (0.1 M) alone are profoundly resistant to the ability of insulin to stimulate lipogenesis acutely. In contrast, primary cultures of hepatocytes incubated with dexamethasone plus insulin are hyper-responsive to the ability of insulin to stimulate lipogenesis chronically. This potentiation of insulin action by a glucocorticoid occurs at physiological concentrations of the two hormones. Exposure to dexamethasone plus insulin for more than 4h is required for the two hormones to enhance insulin action either by overcoming the insulin resistance induced by dexamethasone alone or by stimulating insulin action induced by insulin alone. Despite the marked potentiation of insulin action, hepatocytes exposed to dexamethasone plus insulin are less sensitive to insulin, as demonstrated by a shift to the right in the dose-response curve for insulin-stimulated lipogenesis. The resistance of hepatocytes to the acute effects of insulin after exposure to dexamethasone alone and the potentiation of insulin action and decreased sensitivity to insulin after exposure to insulin plus dexamethasone are all mediated by post-insulin-binding events. These studies demonstrate potentiation of insulin action in the liver by physiological concentrations of glucocorticoids and may have physiological significance for the regulation of normal hepatic lipogenesis, for the hyperlipidaemia observed with the pharmacological use of glucocorticoids, and for disease states in man associated with hyperinsulinaemia and hypercortisolism.
Increased concentrations of glucocorticoids in humans and animals are associated with enhanced hepatic rates of lipogenesis and increased hepatic and plasma lipids (Baker et al., 1948; Steinberg et al., 1952; Soffer et al., 1961; Stern et al., 1973; Casaretto et al., 1974; Reaven et al., 1974; Diamant & Shafrir, 1975; Bagdade et al., 1976a,b; Kirk et al., 1976) . In addition, physiological concentrations of glucocorticoids in conjunction with insulin are required for the enhanced lipogenesis associated with refeeding after starvation (Berdanier & Shubeck, 1979; Bouillon & Berdanier, 1980) . The relative roles of these two hormones in this hyperlipogenic response are unknown. It has been suggested that the increased insulin concentrations associated with glucocorticoid excess, or a synergism between glucocorticoids and insulin, as in refeeding, may mediate the enhanced hepatic lipogenesis (Kirk et al., 1976; Berdanier & Shubeck, 1979) . If so, this would represent a situation of differential responsiveness to glucocorticoids, since glucocorticoids induce insulin resistance for some biological responses in the liver when administered in vivo or in vitro (Caro & Amatruda, 1982) . Although the exact mechanism of this insulin resistance is also unknown, studies in our laboratory with freshly isolated hepatocytes from glucocorticoid-treated animals and primary cultures of hepatocytes exposed to dexamethasone (0.1 pM) indicate that the insulin resistance in the liver with regard to aminoisobutyrate uptake is due to post-binding mechanisms (Caro & Amatruda, 1982) . The direct effects of glucocorticoids on the liver are to increase insulin binding and to induce resistance to the ability of insulin both to stimulate amino acid uptake and to down-regulate its receptors (Caro & Amatruda, 1982) .
To define further the effects of glucocorticoids on another metabolic process in the liver and to establish the nature of the interrelationships between insulin and glucocorticoids on this process, we have evaluated lipogenesis in primary cultures of hepatocytes exposed to dexamethasone and insulin, separately or together. Primary cultures of hepatocytes were used because they allow us to evaluate the effects of these hormones singly and combined without the complicating changes in substrate and hormonal milieu that occur in vivo.
The data indicate that dexamethasone alone leads to an insulin-resistant state with regard to lipogenesis much the same as we have previously demonstrated for amino acid uptake (Caro & Amatruda, 1982) . The combination of dexamethasone plus insulin, however, leads to a marked enhancement of insulin-stimulated lipogenesis. Thus, under conditions where insulin is present, glucocorticoids are permissive for stimulation of lipogenesis by insulin, whereas under conditions of insulin lack glucocorticoids induce or aggravate insulin resistance.
Experimental
Male Sprague-Dawley rats (200-300g) fed ad libitum were used for all experiments. The isolation of liver cells and preparation of primary cultures of rat hepatocytes on collagen-coated plates in serumfree medium was as previously described (Caro & Amatruda, 1980a,b; Cech et al., 1980; Amatruda et al., 1982) . Any additions to the culture medium were added at the time of the first change of medium, 3-4 h after plating. Insulin was added again 16 h later and 4h after this the cells were washed at 37°C with Hanks-Hepes [4-(2-hydroxymethyl)-1 -piperazineethanesulphonic acid) buffer, pH 7.4, containing 8 mM-glucose and albumin (10 mg/ml).
To measure lipid synthesis, [114Clacetate (5mM; 2.2uCi/ml) was added to the culture plates containing the above Hanks-Hepes buffer and the incubation was continued at 370C for 2h. The plates were then washed in cold phosphate-buffered saline, pH 7.4, and the cellular lipids were extracted by the method of Bligh & Dyer (1959) as previously reported . In some experiments lipid synthesis was measured by the incorporation of 3H20 (0.6 mCi/mI) plus 5mM unlabelled acetate . Binding of 1251-labelled insulin was measured as previously reported (Caro & Amatruda, 1980a,b; Cech et al., 1980; Amatruda et al., 1982) 
Results
Previous studies in our laboratory demonstrated that the exposure of primary cultures of hepatocytes to glucocorticoids leads to insulin resistance with regard to amino acid uptake (Caro & Amatruda, 1982) . The present studies evaluating lipogenesis resulted in similar findings. The acute (2h) lipogenic response to insulin of primary cultures of hepatocytes from normal rats was evaluated after a 16h exposure to dexamethasone (0.1 ,M). These data are illustrated in Fig. 1 and demonstrate a profound Since the lipogenic response to insulin is so low in dexamethasone-treated cells (Fig. 1) , a concentration of insulin eliciting a half-maximal response (ED50) cannot be accurately determined. However, in the control cultures the ED50 for insulin is 0.4nM, which is similar to that previously reported from our laboratory (Caro & Amatruda, 1980a,b; Cech et al., 1980; Amatruda et al., 1982) . Under the conditions of the present studies, insulin binding is increased, as we have previously reported (results not shown). (Caro & Amatruda, 1982) , indicating that the dexamethasone-induced insulin resistance is due to post-binding mechanisms.
In contrast with the acute response to insulin, when primary cultures of hepatocytes are incubated in the presence of dexamethasone (0.1 M) plus various concentrations of insulin for 20h lipogenesis is markedly enhanced (Fig. 2) . At lOnMinsulin the enhancement of lipogenesis by dexamethasone plus insulin is 3.6-fold (4.9-fold at 100nM-insulin) greater than that observed with insulin alone (Fig. 2) . This enhancement of lipogenesis is significant at all insulin concentrations (P<0.05 to P<0.0125 by paired t test). These data were also confirmed with 3H20. At 10 nM-insulin plus 0.1 M-dexamethasone, insulin-stimulated lipogenesis was enhanced 4.6-fold over that observed with insulin alone (P < 0.005). Although this enhancement of lipogenesis occurs at physiological concentrations of insulin, dexamethasone also has a significant effect on insulin sensitivity. tively (P <0.025 by paired t test). This significant decrease in insulin sensitivity (Fig. 2) in the presence of an increase in insulin binding in previously published studies (Caro & Amatruda, 1982) again indicates that post-binding mechanisms can regulate both the sensitivity and responsiveness to insulin . In addition, the present data indicate that these two parameters can be regulated in opposite directions, i.e. cells treated with dexamethasone plus insulin have a decrease in sensitivity and an increase in responsiveness to insulin.
To determine the dose-response relationship for the enhancement of lipogenesis by dexamethasone, we incubated primary cultures of hepatocytes for 20h in the presence of various concentrations of dexamethasone (1 nM-0. 1,uM) and a fixed concenVol. 212 tration of insulin (10 nM). Lipogenesis was then evaluated. A significant glucocorticoid effect was observed at 1nM-dexamethasone (Fig. 3) Fig. 4 , insulin action is maximal by 2h of preincubation (P<O.1 for 2 versus 4h). With more prolonged preincubation with insulin, no further increase in insulin's effect was observed. In additional experiments, primary cultures of hepatocytes were incubated with dexamethasone for 20h and insulin was added for the full 20h incubation or for the final 12, 4, 2 or Oh. Lipogenesis was then evaluated from [1-14C]acetate. As illustrated in Fig.   4 , as compared with insulin alone, cultures incubated with dexamethasone for 20h were resistant to insulin's effect on lipogenesis for 2 and 4 h (P < 0.01). By 12h insulin is able to overcome this resistance, and insulin-stimulated lipogenesis is enhanced 2.2-fold in the presence of dexamethasone for 20h and insulin for 12h. When both insulin and dexamethasone are included for 20 h there is a 3.4-fold enhancement of insulin action. Thus dexamethasone-induced insulin resistance is present only within 4h of insulin exposure. After this time, the two hormones act together to enhance insulin responsiveness. In primary cultures of hepatocytes incubated with insulin for 20h, dexamethasone has no effect on insulin-stimulated lipogenesis for the first 4h of exposure to dexamethasone, i.e. cultureg are incubated with 10nM-insulin for 20h and O.lpM-dexamethasone is added at 16h and 18h of incubation or at 4 and 2h before measurement of ['4C ]acetate incorporation into lipids (Fig. 4) . When dexamethasone is added for the final 12h and the entire 20h of culture, the data are identical with those for the cultures in which insulin is added after dexamethasone. Thus exposure to insulin plus dexamethasone must be for greater than 4h for the methasone alone or by stimulating insulin action induced by insulin alone. Fig. 4(b) illustrates these time-course data as a percentage of the maximal effect observed; clearly the maximal effect of insulin alone is reached by 2-4 h, whereas in the presence of dexamethasone the time of appearance of the maximal insulin effect is markedly retarded.
Discussion
The role of glucocorticoids in the regulation of hepatic lipogenic enzymes and lipogenesis has been .studied in intact animals and in the perfused rat liver (Altman et al., 1951; Diamant & Shafrir, 1975; Kirk et al., 1976) . This effect of glucocorticoids was first demonstrated by Altman et al. (1951) , who showed that pharmacological amounts of insulin and glucocorticoids act synergistically to enhance lipogenesis in the perfused liver. Subsequent studies indicated that the administration of glucocorticoids to rats increases the activity of hepatic acetyl-CoA carboxylase and fatty acid synthetase as well as lipogenesis from [1-'4C]acetyl-CoA (Diamant & Shafrir, 1975) . These effects were not present in alloxan-diabetic rats, suggesting that insulin is a necessary mediator of the glucocorticoid effect. Additional studies in starved-refed rats indicate that the increase in glucose 6-phosphate dehydrogenase and malic enzyme activities which is present in normal rats is not demonstrable in adrenalectomized, streptozotocin-diabetic and adrenalectomizeddiabetic rats (Berdanier & Shubeck, 1979) . Treatment with glucocorticoids, insulin, and both hormones in the respective groups restores the hepaticenzyme overshoot associated with refeeding (Berdanier & Shubeck, 1979) . From those studies it has been suggested that insulin may be responsible for the regulation of substrate flux into lipogenic pathways, and glucocorticoids and insulin may be responsible for enzyme protein synthesis de novo (Berdanier & Shubeck, 1979) . In addition, in perfused livers from adrenalectomized rats, lipogenesis from 3H20 and 14C-labelled precursors is decreased (Kirk et al., 1976) . Cortisol addition to the perfusion has no stimulatory effect on lipogenesis, whereas fatty acid synthesis is restored to normal in perfused livers from adrenalectomized rats within 5 h after treatment of the animal with cortisol in vivo. These studies suggested that both insulin and glucocorticoids are necessary for normal hepatic lipogenesis. Glucocorticoid excess in both animals and man leads to hepatic lipid accumulation (Baker et al., 1948; Steinberg et al., 1952; Soffer et al., 1961; Reaven et al., 1974) and increased synthesis and secretion of very-low-density lipoproteins (Stern et al., 1973; Casaretto et al., 1974; Bagdade et al., 1976a,b) and in some cases low-density lipoproteins (Bagdade et al., 1976a) . Taken together, the above studies suggest that glucocorticoids may be necessary for maximum expression of insulin-stimulated lipogenesis in the liver and indicate that glucocorticoid excess is associated with increased hepatic lipogenesis.
Our studies confirm and extend these observations. First, as we have previously shown for aminoisobutyrate uptake (Caro & Amatruda, 1982) , glucocorticoids in the absence of insulin lead to a profound resistance to the lipogenic effects of subsequently added insulin (Fig. 1) . This resistance, is due to post-binding mechanisms, since glucocorticoids alone increase insulin binding (Caro & Amatruda, 1982) . Thus glucocorticoid-induced insulin resistance can now be generalized to at least two biological responses in the liver. Secondly, the glucocorticoid-induced insulin resistance is reversed after 4 h exposure to insulin in the presence of glucocorticoids (Fig. 4) . After this the two hormones act together to potentiate insulin's stimulation of lipogenesis. This potentiation is also a post-binding enhancement of insulin action, since insulin binding in the presence of insulin plus dexamethasone is the same as that in the presence of dexamethasone alone (Caro & Amatruda, 1982) .
Thirdly, the potentiation of insulin action by dexamethasone occurs at glucocorticoid concentrations equivalent to physiological concentrations of cortisol in man (Fig. 3) . The onset of the effect is at an equivalent cortisol concentration of 1.5,ug/100ml and the maximal rate of increase at a cortisol equivalent of 1.5-15,ug/lOOml. This suggests that the effect may be physiologically meaningful. Fourthly, the glucocorticoid effect is observed at physiological concentrations of insulin with an insulin dose-response relationship which is similar to that for insulin alone (Fig. 2) . There is, however, a significant rightward shift in the dose-response curve for insulin-stimulated lipogenesis in the presence of dexamethasone (Fig. 2) . In conjunction with our previous data, indicating that insulin binding is equally increased in the presence of dexamethasone and dexamethasone plus insulin (Caro & Amatruda, 1982) , these data again suggest that alterations in insulin sensitivity in addition to insulin responsiveness can be mediated by post-binding mechanisms .
Finally, our data may have physiological significance for the regulation of normal hepatic lipogenesis and for disease states in man. Since the enhancement of insulin-stimulated lipogenesis is observed at concentrations of glucocorticoids equivalent to physiological values in man, it is likely that the two hormones act together to regulate normal hepatic lipogenesis and perhaps the hyperlipidaemia associated with increased plasma insulin (Olefsky et al., 1974) . Also, the heptic steatosis and hyperlipidaemia associated with exogenous or endogenous glucocorticoid excess (Baker et al., 1948; Steinberg et al., 1952; Soffer et al., 1961; Stern et al., 1973; Casaretto et al., 1974; Reaven et al., 1974; Bagdade et al., 1976a,b) can now be explained by an enhancement of insulin-stimulated lipogenesis by glucocorticoids. Since glucocorticoid excess results in increased plasma insulin, the two hormones together would act additively in the liver to enhance lipogenesis. In fact, increased synthesis and secretion of very-low-density lipoproteins have been shown in states of glucocorticoid excess (Bagdade et al., 1976a,b; Stern et al., 1973) . This, in conjunction with increased lipoprotein lipase activity (Stern et al., 1973; Pykalisto et al., 1975) , might increase adipose-tissue fat stores, leading to enlargement of fat-cells, and subsequent insulin resistance of adipocytes (Czech et al., 1977) . This indirect induction of insulin resistance in adipocytes might be additive to other effects of glucocorticoids in these cells to decrease the activity of lipogenic enzymes (Diamant & Shafrir, 1975) and glucose transport (Livingston & Lockwood, 1975) . Thus glucocorticoid potentiation of insulin action in the liver in conjunction with increased insulin concentrations may explain many of the observed metabolic alterations associated with hypercortisolism.
Further studies are required to elucidate the mechanism(s) by which glucocorticoids enhance insulin-stimulated hepatic lipogenesis. It is possible, however, that glucocorticoids modulate the synthesis of hepatic lipogenic enzymes and insulin modulates the synthesis and activity of these enzymes.
